查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1208611

2023-2030 年膝關節植入物的全球市場

Global Knee Implants Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

膝關節植入物的全球市場規模預計到 2022 年將達到 124.4 億美元，在預測期內（2023-2030 年）以 4.56% 的複合年增長率增長。

膝關節承重面的手術置換可減輕疼痛和殘疾。 這種手術最常被推薦用於其他膝關節疾病，如類風濕性關節炎和銀屑病關節炎，以及其他保守治療無法緩解關節疼痛的情況。 對於患有晚期類風濕性關節炎、外傷或慢性骨關節炎等嚴重畸形的患者，手術可能會更加困難和危險。 因此，它不能證明全膝關節置換術的合理性。

市場動態

推動全球膝關節植入物市場的主要因素是骨相關疾病和事故發生率的上升，這正在推動市場的繁榮；其中包括全膝關節置換術的普及、膝關節置換術技術的改進、以及由於新興國家肥胖症的增加，膝關節植入物市場的預期擴張。

骨骼相關疾病和事故發生率的上升正在推動市場繁榮。

根據美國國家醫學圖書館的資料，骨折可能是患者骨病的第一個明顯跡象，是由骨病（尤其是骨質疏鬆症）引起的主要問題。 據估計，每年有 150 萬人因骨病而骨折。 骨質疏鬆症是骨折的最常見原因。 在美國，大約有 1000 萬 50 歲以上的人患有髖部骨質疏鬆症。 另有 3360 萬 50 歲以上的人髖關節骨量低，通常稱為“骨質減少”，使他們面臨骨質疏鬆症和未來可能出現並發症的風險。

也很明顯，到 2021 年，僅在美國，膝關節置換手術預計每年就會進行約 80 萬次。 根據棕櫚灘的個性化骨科，這個數字逐年增加。 膝關節置換手術主要是門診手術，因為手術和骨骼狀況推動了膝關節植入物的市場。

世界衛生組織估計，全世界每年有 130 萬人死於道路交通事故，另有 20 至 5000 萬人遭受非致命傷害。 一半以上的交通死亡事故是由行人、騎自行車的人、摩托車和他們所載的人造成的。 前面提到的變量導致對膝關節植入物的需求增加。

缺乏熟練的外科醫生和高成本預計會阻礙市場增長。

骨科手術的高成本和經驗豐富的醫生的短缺需要市場的改善。

COVID-19 影響分析

COVID-19 流行病導致廣泛的手術限制和種植手術取消，導致骨科和醫療器械行業的收入損失慘重。 為了減少交叉感染的機會，醫院行業選擇了擇期手術，限制了被證明對醫務人員有潛在風險的手術數量。 由於交叉感染的可能性，大流行期間不得不推遲一些手術。 受疫情影響，膝關節置換市場的就業人數迅速下降，對人們的可支配收入產生了重大影響。

恢復擇期膝關節置換服務的一個主要障礙是政府對醫療實踐和擇期手術的限制和禁令。 此外，在大流行之後，一些醫院和門診服務中心於 2020 年 12 月恢復為患者提供擇期關節置換術服務，同時採取了所有必要的安全措施。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 與骨骼相關的疾病和事故的發生率不斷增加，推動了市場的繁榮。
      • 人工膝關節手術技術改進
    • 約束因素
      • 骨科手術費用高，經驗豐富的醫生短缺，需要市場改善
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 全膝關節置換術
  • 部分膝關節置換術
  • 膝關節置換術（修訂版）

第 8 章按組件類型

  • 固定膝關節假體 (FBI)
  • 可移動植入物

第 9 章最終用戶

  • 醫院
  • 門診手術中心
  • 骨科診所

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第12章公司簡介

  • 捷邁邦美
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Corin Group
  • Stryker Corp
  • DePuy Synthes
  • Smith and Nephew
  • Aesculap Implants Systems, LLC
  • Exactech, Inc.
  • MicroPort Scientific
  • CONMED, Kinamed, Inc.
  • ConforMIS

第13章 DataM

簡介目錄
Product Code: DMMD1528

Market Overview

The global knee implants market size was valued at US$ 12.44 billion in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 4.56% during the forecast period (2023-2030).

The weight-bearing surfaces of the knee joint are replaced surgically to relieve pain and disability; this procedure is most frequently recommended when other conservative measures are ineffective at reducing joint pain, as well as for other knee diseases like rheumatoid arthritis and psoriatic arthritis. Surgery may be more difficult and risky in patients with significant deformities brought on by advanced rheumatoid arthritis, trauma, or chronic osteoarthritis. Hence it is not a justification for knee replacement surgery.

Market Dynamics

The major factors driving the global knee implants market are the incidence of bone-related diseases and accidents is rising, which is driving the market to flourish, bicruciate-retaining total knee arthroplasty is becoming more popular, improvements in technology for knee replacement surgery and the market for knee implants are anticipated to expand as the number of obese people increases in emerging economies.

The incidence of bone-related diseases and accidents is rising, driving the market to flourish.

According to the National Library of Medicine, U.S., fractures, which could be the first outward sign of bone disease in patients, are the major issue brought on by bone disease, particularly osteoporosis. An estimated 1.5 million people experience a fracture due to a bone condition every year. The most common reason for fractures is osteoporosis. In the U.S., there are about 10 million people over 50 who have hip osteoporosis. An additional 33.6 million people over 50 have low hip bone mass, often known as "osteopenia," putting them at risk for osteoporosis and any potential complications in the future.

And the year 2021 reveals that knee replacement surgery is such a common procedure that it is anticipated to be carried out around 800,000 times annually in the United States alone. That number rises yearly, according to Personalized Orthopedics of the Palm Beaches. Most knee replacements are outpatient procedures due to surgeries and bone conditions boosting the market for knee implants.

The WHO estimates that 1.3 million people die in traffic accidents each year around the world, and another 20 to 50 million people get non-fatal injuries. More over half of all fatalities and injuries caused by traffic accidents involve pedestrians, cyclists, motorcyclists, and the people they are carrying. The previously mentioned variables have led to a rise in the demand for knee implants.

Lack of skilled surgeons and high cost are expected to hamper the market's growth.

The market needs to be improved by the high cost of orthopedic surgeries and the scarcity of experienced doctors.

COVID-19 Impact Analysis

The COVID-19 epidemic resulted in significant revenue losses for the orthopaedic and medical device industries due to widespread surgical restrictions and implant procedure cancellations. The hospital industry chose elective operations by limiting the number of procedures performed, which will prove to be a potential risk for the medical staff, to reduce the likelihood of cross-infection. The potential of cross-infection forced several surgeries to be postponed during the pandemic. The market for knee replacement surgery was severely impacted by the pandemic's quick fall in employment, which impacted people's disposable income.

A major obstacle to restoring elective knee arthroplasty services was the government's limitations and bans on medical procedures and elective surgeries. Additionally, after the pandemic, several hospitals and ambulatory service centers resumed providing elective arthroplasty services to patients in December 2020 while taking all necessary safeguards.

Segment Analysis

The total knee replacement segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The total knee replacement segment is the highest market holder in the global knee implants market Due to the increasing demand for implants and the customized replacement systems provided by businesses, Total Knee Replacement (TKR) is dominating. The considerable patient base of people living with arthritis and the rise in the number of patients receiving the operation are further reasons that contribute to the segment's high proportion of the market. Severe osteoarthritis can be effectively treated with total knee arthroplasty (TKA). TKA results in a good recovery from surgery, good survival rates, and general functional improvement. The main surgical objective continues to be to meet the functional expectations of patients having TKA. Consider total knee replacement surgery if nonsurgical options like medication and using walking aids are no longer effective.

The companies are working consistently to deliver cutting-edge, individualized TKR systems centered on certain patients' requirements. For instance, in December 2021, the first surgery in the U.S. to successfully use Pixee Medical, an FDA-cleared augmented reality surgical application for help in total knee arthroplasty, was completed by MicroPort Orthopedics, a world leader in orthopedic equipment and technologies. Through smart glasses and a unique platform called Knee+ from Pixee Medical, orthopedic surgeons may execute operations more effectively and quickly thanks to real-time instrument positioning. Since 90% of surgeons who use a conventional approach and have never used navigation or robotics find Knee+ intuitive, little training is necessary for them to use it.

In November 2022, the reverse hybrid construct for complete knee arthroplasty, the JOURNEY II ROX Total Knee Solution, was unveiled by Smith+Nephew, a leading medical technology provider worldwide. A new procedural product solution has been developed to give surgeons the therapeutic benefit of cutting-edge bearing material and anatomic design along with the effectiveness and potential long-term tibia fixation of a cementless knee.

Geographical Analysis

North America holds the largest market share in the global knee implants market.

North America dominates the global knee implants market primarily due to its large population, excellent medical infrastructure, and high-income levels. Due to the aging population who need knee replacement surgery, North America has grown to be the largest market. This region's rise has largely been attributed to the top market players' presence there. The people's access to high disposable income has made it possible for them to choose cutting-edge medical techniques that incorporate robot assistance and artificial intelligence.

For instance, in September 2021, Zimmer Biomet acquired FDA 510(k) clearance for the ROSA Hip System for robotically-assisted anterior complete hip replacement in order to broaden its ROSA Robotics portfolio, which already includes the ROSA Knee System for total and partial knee replacement. Additionally, the Persona I.Q., supposedly the first and only smart knee approved by the FDA for total knee replacement, was given a De Novo designation by the FDA so that Zimmer Biomet and Canary Medical may market it.

The increase is the result of several reasons, including an increase in accidents and people with degenerative conditions. For instance, according to a report released in June 2021 by the Canadian Institute for Health Information, approximately 75,073 knee replacements were carried out in Canada year 2020. Additionally, it stated that more than 1.4 billion U.S. dollars are spent annually on knee replacement surgeries in Canada.

Competitive Landscape

The Knee Implants market is moderately competitive with local and global companies' presence. Zimmer Biomet, Corin Group, Stryker Corp, DePuy Synthes, Smith and Nephew, Aesculap Implants Systems, LLC, Exactech, Inc., MicroPort Scientific, CONMED, Kinamed, Inc. ConforMIS .and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, inmARCH 2019, the US-based OMNI Orthopedics, a pioneer in robotic-assisted complete knee replacement, has been acquired by UK international orthopedic corporation Corin Group ("Corin"), funded by the Permira funds..

Smith and Nephew.

Overview: The development, production, and marketing of medical devices for use in orthopaedic reconstruction and trauma, sports medicine, ENT, and advanced wound treatment are the main business activities of Smith & Nephew Plc (Smith & Nephew). The business provides robotics-assisted enabling technologies, trauma products to fix fractures, and knee and hip implants to repair diseased, old, or injured joints.

Product Portfolio:

Genesis II: The GENESIS II Total Knee System has developed into one of the industry's most dependable total knee systems. GENESIS II was built with the most advanced equipment, including the user-friendly MIS system and the ream-through femoral trials, to produce the most complete system..

The global knee implants market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The incidence of bone-related diseases and accidents is rising, driving the market to flourish.
      • 4.1.1.2. Improvements in technology for knee replacement surgery
    • 4.1.2. Restraints:
      • 4.1.2.1. The market needs to be improved by the high cost of orthopedic surgeries and the scarcity of experienced doctors
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Total knee replacement
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Partial knee replacement
  • 7.4. Revision knee replacement

8. By Component Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 8.1.2. Market Attractiveness Index, By Component Type
  • 8.2. Fixed-bearing Implants
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Mobile-bearing Implants

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory surgical centers
  • 9.4. Orthopedic clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size AnalysisUS$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Zimmer Biomet
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Corin Group
  • 12.3. Stryker Corp
  • 12.4. DePuy Synthes
  • 12.5. Smith and Nephew
  • 12.6. Aesculap Implants Systems, LLC
  • 12.7. Exactech, Inc.
  • 12.8. MicroPort Scientific
  • 12.9. CONMED, Kinamed, Inc.
  • 12.10. ConforMIS

LIST NOT EXHAUSTIVE

13. Global Knee Implants Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us